Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  EMIS Group plc    EMIS   GB00B61D1Y04

EMIS GROUP PLC

(EMIS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

EMIS : Health appointed to NHS GP IT Futures framework

10/21/2019 | 04:21am EST

The Framework replaces GP Systems of Choice (GPSoC), the current contractual framework, to supply IT systems and services to the GP market in England. It will commence on 1 January 2020 and, subject to a break option after the first year, is capable of running until 31 March 2023. The Framework will govern the provision of the majority of EMIS Group's clinical IT system-related services to GPs in England.

All suppliers appointed to the Framework will also require separate approval for their products and services to be placed on the Digital Buying Catalogue (the 'Catalogue'). This is the online platform through which clinical IT systems will be procured under GP IT Futures, to allow them to sell their products and services. This is a detailed process to ensure that individual products and GP systems meet strict clinical safety and operational requirements similar to the high standards that the Group's EMIS Web product meets today. EMIS Group is at an advanced stage of this approval process.

The Board views this award of a place on the Framework to EMIS Health as a positive development for the Group. Subject to Catalogue approval, the Group expects it to result in broadly consistent payments for equivalent product capabilities, in line with management's expectations. Payment for the majority of services under GP IT Futures will be according to the number of patients covered, rather than the number of practices served, as is currently the case under GPSoC. In addition, the Framework is expected to offer new opportunities through the broader scope of the Catalogue, which extends beyond core systems to a much wider range of supporting products and services.

Andy Thorburn, Chief Executive Officer of EMIS Group, said: 'We are pleased to have been awarded a place on the new GP IT Futures framework. We are now focused on completing the Catalogue approval process, which should allow EMIS Health to continue providing joined-up technology to the NHS market for years to come, while positioning the Group positively for the future with potential growth opportunities for both EMIS Web and the broader EMIS Group portfolio.'

Disclaimer

EMIS Group plc published this content on 21 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 October 2019 08:20:09 UTC


© Publicnow 2019
All news about EMIS GROUP PLC
03:44aEMIS : FY20 Revenue, Adjusted Operating Profit To Remain Stable
MT
2020Vodafone Idea Partners with Bajaj Finance for Financing Options for Smartphon..
MT
2020Caixin, CITIC Capital to Sell Emerging Markets Data Unit for $180 Million
MT
2020EMIS GROUP PLC : Ex-dividend day for interim dividend
FA
2020EMIS : shortlisted for two AIM awards
PU
2020EMIS GROUP PLC : half-yearly earnings release
2020FULL YEAR OUTLOOK MAINTAINED : a research report by Edison
PU
2020EMIS GROUP PLC : Ex-dividend day for final dividend
FA
2020EMIS : Final Results
PU
2020EMIS GROUP PLC : annual earnings release
More news
Financials
Sales 2020 158 M 217 M 217 M
Net income 2020 28,5 M 39,2 M 39,2 M
Net cash 2020 43,4 M 59,6 M 59,6 M
P/E ratio 2020 24,5x
Yield 2020 2,90%
Capitalization 697 M 951 M 956 M
EV / Sales 2020 4,13x
EV / Sales 2021 3,92x
Nbr of Employees 1 605
Free-Float 92,5%
Chart EMIS GROUP PLC
Duration : Period :
EMIS Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EMIS GROUP PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 1 222,00 GBX
Last Close Price 1 110,00 GBX
Spread / Highest target 21,6%
Spread / Average Target 10,1%
Spread / Lowest Target 0,54%
EPS Revisions
Managers and Directors
NameTitle
Andrew John Thorburn Chief Executive Officer & Executive Director
Patrick Jean-Marie de Smedt Chairman
Peter John Southby Chief Financial Officer & Executive Director
Shaun O’Hanlon Chief Medical Officer
Pete Malcolm Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
EMIS GROUP PLC2.59%951
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED19.87%47 613
VEEVA SYSTEMS INC.5.66%43 572
OMNICELL, INC.2.25%5 192
SECTRA AB (PUBL)1.43%3 432
PRO MEDICUS LIMITED22.86%3 384